• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在对丝状真菌进行阿尼芬净药敏试验中，将纸片扩散法与微量稀释法进行比较的评估。

Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.

作者信息

Maida Carmelo Massimo, Milici Maria Eleonora, Trovato Laura, Oliveri Salvatore, Amodio Emanuele, Spreghini Elisabetta, Scalise Giorgio, Barchiesi Francesco

机构信息

Istituto di Malattie Infettive e Medicina Pubblica, Università Politecnica delle Marche, Azienda Ospedaliera-Universitaria, Ospedali Riuniti, Torrette di Ancona, Ancona, Italy.

出版信息

J Clin Microbiol. 2008 Dec;46(12):4071-4. doi: 10.1128/JCM.01088-08. Epub 2008 Oct 15.

DOI:10.1128/JCM.01088-08
PMID:18923014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2593298/
Abstract

Susceptibility testing of anidulafungin (AFG) against 32 mold isolates showed an excellent correlation between disk diffusion (DD) and broth microdilution methods. Based on our data, a 2-microg disk of AFG and a 24-h reading time might represent the best parameters for AFG DD testing against filamentous fungi.

摘要

阿尼芬净（AFG）对32株霉菌分离株的药敏试验表明，纸片扩散法（DD）和肉汤微量稀释法之间具有良好的相关性。根据我们的数据，2μg阿尼芬净纸片和24小时的读数时间可能是针对丝状真菌进行阿尼芬净DD试验的最佳参数。

相似文献

1
Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi.在对丝状真菌进行阿尼芬净药敏试验中，将纸片扩散法与微量稀释法进行比较的评估。
J Clin Microbiol. 2008 Dec;46(12):4071-4. doi: 10.1128/JCM.01088-08. Epub 2008 Oct 15.
2
Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.泊沙康唑对丝状真菌临床分离株的抗真菌药敏试验中，纸片扩散法和Etest法与肉汤微量稀释法的比较评估
J Clin Microbiol. 2007 Apr;45(4):1322-4. doi: 10.1128/JCM.02450-06. Epub 2007 Jan 31.
3
Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.评估纸片扩散法与肉汤微量稀释法检测 3 种棘白菌素类抗真菌药物对曲霉菌属的药敏试验
Diagn Microbiol Infect Dis. 2012 May;73(1):53-6. doi: 10.1016/j.diagmicrobio.2012.01.006. Epub 2012 Apr 4.
4
Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole.采用两性霉素B、卡泊芬净、伊曲康唑、泊沙康唑和伏立康唑，比较Neo-Sensitabs片剂扩散法与CLSI肉汤微量稀释法M38-A及纸片扩散法检测丝状真菌药敏性的效果。
J Clin Microbiol. 2008 May;46(5):1793-803. doi: 10.1128/JCM.01883-07. Epub 2008 Mar 12.
5
Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.用于确定临床真菌分离株对卡泊芬净敏感性的纸片扩散法和微量稀释法的比较。
J Clin Microbiol. 2007 Nov;45(11):3529-33. doi: 10.1128/JCM.00826-07. Epub 2007 Aug 29.
6
Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo.阿尼芬净对黑曲霉的体外和体内疗效。
Int J Antimicrob Agents. 2011 Oct;38(4):360-3. doi: 10.1016/j.ijantimicag.2011.06.008. Epub 2011 Aug 6.
7
Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds.针对阿尼芬净对霉菌药敏试验的CLSI肉汤微量稀释法（M38-A文件）的质量控制和参考指南。
J Clin Microbiol. 2007 Jul;45(7):2180-2. doi: 10.1128/JCM.00399-07. Epub 2007 May 2.
8
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.临床分离曲霉菌属对安尼鲁单抗、卡泊芬净和米卡芬净的体外药敏性：CLSI M38-A2 肉汤微量稀释法头对头比较。
J Clin Microbiol. 2009 Oct;47(10):3323-5. doi: 10.1128/JCM.01155-09. Epub 2009 Aug 26.
9
[In vitro antifungal activity of anidulafungin].[阿尼芬净的体外抗真菌活性]
Rev Iberoam Micol. 2008 Jun;25(2):83-91. doi: 10.1016/s1130-1406(08)70025-1.
10
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.新型三唑类药物SCH56592与棘白菌素类药物MK-0991（L-743,872）和LY303366对机会性丝状真菌、双相真菌和酵母的体外活性比较。
J Clin Microbiol. 1998 Oct;36(10):2950-6. doi: 10.1128/JCM.36.10.2950-2956.1998.

引用本文的文献

1
inhibitory activity of BB536 and HN001 alone or in combination against bacterial and reference strains and clinical isolates.BB536和HN001单独或联合使用对细菌、参考菌株及临床分离株的抑制活性。
Heliyon. 2019 Nov 22;5(11):e02891. doi: 10.1016/j.heliyon.2019.e02891. eCollection 2019 Nov.
2
Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.基于琼脂的曲霉属棘白菌素敏感性筛选方法的开发和多中心验证。
J Antimicrob Chemother. 2019 Aug 1;74(8):2247-2254. doi: 10.1093/jac/dkz154.
3
Preparation, Characterization, and Antimicrobial Properties of Chitosan-Silver Nanocomposites Films Against Fish Pathogenic Bacteria and Fungi.壳聚糖-银纳米复合膜对鱼类致病细菌和真菌的制备、表征及抗菌性能
Indian J Microbiol. 2017 Dec;57(4):427-437. doi: 10.1007/s12088-017-0670-4. Epub 2017 Aug 22.
4
Multimodal surgical and medical treatment for extensive rhinocerebral mucormycosis in an elderly diabetic patient: a case report and literature review.老年糖尿病患者广泛鼻脑型毛霉菌病的多模式手术及药物治疗：一例报告及文献综述
Case Rep Med. 2014;2014:527062. doi: 10.1155/2014/527062. Epub 2014 May 27.

本文引用的文献

1
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.欧洲癌症研究与治疗组织/侵袭性真菌感染合作组和美国国立过敏与传染病研究所真菌病研究组（EORTC/MSG）共识组对侵袭性真菌病的修订定义。
Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.
2
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.曲霉病的治疗：美国传染病学会临床实践指南
Clin Infect Dis. 2008 Feb 1;46(3):327-60. doi: 10.1086/525258.
3
Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.用于确定临床真菌分离株对卡泊芬净敏感性的纸片扩散法和微量稀释法的比较。
J Clin Microbiol. 2007 Nov;45(11):3529-33. doi: 10.1128/JCM.00826-07. Epub 2007 Aug 29.
4
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.一种用于丝状真菌对伏立康唑、泊沙康唑、伊曲康唑、两性霉素B和卡泊芬净药敏试验的新型纸片琼脂扩散法的多中心评估
J Clin Microbiol. 2007 Jun;45(6):1811-20. doi: 10.1128/JCM.00134-07. Epub 2007 Apr 11.
5
Development of anidulafungin for disk diffusion susceptibility testing against Candida spp.阿尼芬净用于针对念珠菌属进行纸片扩散药敏试验的研发
Diagn Microbiol Infect Dis. 2007 Jul;58(3):371-4. doi: 10.1016/j.diagmicrobio.2007.01.018. Epub 2007 Mar 26.
6
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.阿尼芬净和卡泊芬净对光滑念珠菌的体内疗效以及在血清存在下与体外效力的相关性。
Antimicrob Agents Chemother. 2007 May;51(5):1616-20. doi: 10.1128/AAC.00105-07. Epub 2007 Feb 16.
7
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.阿尼芬净对2500多株念珠菌临床分离株的体外活性，其中包括315株对氟康唑耐药的分离株。
J Clin Microbiol. 2005 Nov;43(11):5425-7. doi: 10.1128/JCM.43.11.5425-5427.2005.
8
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.造血干细胞移植和实体器官移植后侵袭性曲霉病的发病率：一项前瞻性多中心监测项目的中期结果
Med Mycol. 2005 May;43 Suppl 1:S49-58. doi: 10.1080/13693780400020113.
9
New agents for the treatment of systemic fungal infections--current status.用于治疗全身性真菌感染的新型药物——现状
Expert Opin Emerg Drugs. 2002 May;7(1):3-32. doi: 10.1517/14728214.7.1.3.
10
Initial results from a longitudinal international surveillance programme for anidulafungin (2003).阿尼芬净纵向国际监测项目的初步结果（2003年）
J Antimicrob Chemother. 2004 Dec;54(6):1051-6. doi: 10.1093/jac/dkh504. Epub 2004 Nov 25.